The prospects and limitations of liquid biopsy utilization for clinical practice in Taiwan.

ABSTRACT:

Objective

Liquid biopsy is a promising, non-invasive diagnostic tool for cancer, offering rapid and cost-effective genomic analysis. It provides a less invasive alternative to traditional tissue biopsies, with potential benefits in monitoring disease progression and detecting minimal residual disease (MRD). However, its clinical integration faces challenges, including utility assessment and workflow adaptation. This study evaluates the value of liquid biopsy in Taiwan from a clinical physician's perspective.

Methods

A survey was conducted with 16 physicians specializing in thoracic medicine and hematologic oncology. Participants responded to a 5-point Likert scale to evaluate the timing of liquid biopsy adoption, willingness to incorporate it into clinical practice, and agre

SUBMITTER: Li HY 

PROVIDER: S-EPMC11937291 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature